Form 4: STERIS plc Director Richard C. Breeden Reports Stock Option and Restricted Stock Unit Awards

Director Richard C. Breeden reports the acquisition of stock options and restricted stock units in STERIS plc, including options granted in lieu of fees.

Summary

• Richard C. Breeden, a director of STERIS plc, filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
• On August 8, 2024, Breeden acquired 1,389 stock options with an exercise price of $239.68, expiring on August 8, 2034.
• He also acquired 292 stock options with the same terms, issued in lieu of $25,000 in fees.
• Additionally, Breeden acquired 495 Career Restricted Stock Units (RSUs) and 358 Career Restricted Stock Units (RSUs) issued in lieu of $86,000 in fees, which will be settled in STERIS ordinary shares six months after he ceases to be a director.
• The RSUs are fully vested immediately.
• Following these transactions, Breeden beneficially owns 1,681 stock options and 18,703 Career Restricted Stock Units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock option and RSU grants to a director. There's no inherent positive or negative implication, but it does indicate continued director involvement.

Positives

• The acquisition of stock options and restricted stock units by a director can be seen as a positive sign, indicating confidence in the company's future performance.
• The issuance of stock options in lieu of fees demonstrates a willingness by the director to align his interests with those of the shareholders.

Industry Context

This filing is a routine disclosure of changes in beneficial ownership by a company director, as required by SEC regulations. It provides transparency to investors regarding the holdings and transactions of company insiders.

Stakeholder Impact

• The transactions may have a minor positive impact on shareholder sentiment, as they demonstrate the director's continued investment in the company.

Key Dates